|Bid||6.50 x 1100|
|Ask||10.90 x 800|
|Day's Range||6.33 - 6.70|
|52 Week Range||5.96 - 15.11|
|Beta (3Y Monthly)||0.19|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 27, 2018 - Mar. 5, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.53|
While Kindred Biosciences, Inc. (NASDAQ:KIN) shareholders are probably generally happy, the stock hasn't had...
Kindred Bio (KIN) delivered earnings and revenue surprises of -2.78% and -37.39%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Kindred Bio (KIN) delivered earnings and revenue surprises of 0.00% and -73.62%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The big shareholder groups in Kindred Biosciences, Inc. (NASDAQ:KIN) have power over the company...
Kindred Biosciences, Inc. (NASDAQ:KIN) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case ofRead More...
NEW YORK, Nov. 16, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.